Addex Therapeutics Ltd.
SEC CIK 1574232 · ADXN · last insider filing 2026-03-25
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Mills Roger | Director · CHIEF MEDICAL OFFICER | filed 2026 - 2026 |
| Hill Raymond George | Director | filed 2026 - 2026 |
| Lawton Vincent Michael | Director | filed 2026 - 2026 |
| Nunn Jason Raleigh | Director | filed 2026 - 2026 |
| Manke Isaac | Director | filed 2026 - 2026 |
| Dyer Timothy Mark | Director · Chief Executive Officer | filed 2026 - 2026 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Teyssedou Lenaic Nathanael | PRINCIPAL ACCOUNTING OFFICER | filed 2026 - 2026 |
| Kalinichev Mikhail | HEAD OF TRANSLATIONAL SCIENCE | filed 2026 - 2026 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.